Corti ApS

The Company is a vertically AI product & research company focused on the healthcare & life-science industry. Corti enables healthcare providers, payers, life sciences companies, and healthcare-focused independent software vendors (ISVs) to deploy and operate AI-driven clinical workflows - including autonomous agentic systems - without directly managing foundation models, specialized compute infrastructure, clinical validation frameworks, or regulated operating environments. ​​Core platform components include: ​● Clinical Model Development and Management: Proprietary and fine-tuned models optimized for healthcare-specific tasks, including clinical speech recognition, ambient documentation, and medical coding, supported by domain-specific evaluation and validation frameworks. ​● Agentic Wor…

Development in activities and finances

While investing in its AI Platform, Corti managed to control its operating costs, resulting in an operating loss of DKK 138 million in 2025, compared to DKK 124 million in 2024.

Sustainable Competitive Advantage ​The general-purpose AI market has attracted unprecedented levels of capital and talent. However, healthcare imposes requirements, such as domain-specific training, clinical evaluation, and regulatory readiness, that cannot​be reliably addressed through prompt engineering or generic model deployment alone. ​As a result, healthcare customers increasingly seek AI partners with: ​● Exclusive focus on the healthcare domain ​● Long-term commitment to clinical accuracy and evaluation ​● Infrastructure designed for regulated production environments ​We believe these requirements favor vertically specialized AI platforms that can amortize regulatory and technical​investment across many customers while remaining deeply embedded in healthcare workflows. ​​Commercia…

Profit/loss for the year in relation to expected developments

The operating loss of DKK 138 million in 2025 was expected and reflects our strategic investments in product development.

Corti employs several revenue arrangements in its historic customer contracts, but is increasingly focused on conforming contracts to a usage-based framework, consistent with the AI industry. The timing of revenue is therefore dependent on customer usage, which is typically a function of the customer’s use-case maturity and deployment to the customer's end users.

The value of the recognized development projects depends on the Company's ability to continue developing the ​artificial intelligence (AI) that the company uses in its operations, as well as attracting enough customers, who ​through the platform generate positive earnings that could yield the total investment.

No events have occurred after the balance sheet date to this date that would influence the evaluation of this annual report.